Blood pressure-lowering treatment for primary and secondary prevention of different types of stroke.
High blood pressure is the most important modifiable risk factor for stroke and accumulating evidence indicates that blood pressure levels are likely to be associated with all stroke subtypes. There is also evidence from randomized trials suggesting that blood pressure-lowering treatment provides protection against every stroke subtype in both primary and secondary prevention settings. Blood pressure lowering is likely to be one of the most effective and generalizable strategies across a variety of stroke subtypes.
Arima
Hisatomi
H
George Institute for International Health, University of Sydney and Royal Prince Alfred Hospital, Sydney, PO Box M201, Missenden Road, NSW 2050, Sydney, Australia. harima@george.org.au
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D011322:Primary Prevention / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D055502:Secondary Prevention / Q000379:methods; D020521:Stroke / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*
D000959:Antihypertensive Agents